Grow Opportunities

Grow Biotech

Grow Yourself

2nd Global Biologics India
16-17 April 2025

DNA
Image by mcmurryjulie from Pixabay
Picture drawn by Arun Singhal

Program Agenda - Key Topics and Panel Discussion

This is just preliminary list of topics - a complete program/agenda will be finished by end of January

Cell and Gene Therapy Track

Module 1: Translational and PD issues

Module 2: Manufacturing and Scale up issues

Module 3: Commercialization and Regulatory Challenges

Module 4: CART and NK cell Therapy

Modul 5: iPSCs Therapeutics

Module 6: Facility Design

Module 7: Case Studies

Module 8: Emerging Technologies and Start up companies 

Biosimilar and Novel mAbs Track

Module 1: Clone Development: Lessons learnt and furture directions

Module 2: Downstream and Purification

Module 3: Regulatory and GMP compliance

Module 4: Facility design to meet future demand

Module 5: Business Modality- Challenges and Solutions

Module 6: Emerging technologies and Start up companies

Module 7: Emerging technologies and Start up companies

Module 8: Patent and IP issues

Some of the topics/ titles of talks  that would be discussed…. 

Recent Advances in Process Development and Next Generation Manufacturing for Accelerated and Affordable Biosimilar Development

Successful Commercialization of Cell Therapy products in India

Overview of upstream process development for Biosimilars

Successful Cell Therapy Program: challenges associated with drug manufacturing and process and product characterization

Manufacturing of AAV and lentiviral vectors using HEK293 cells

Challenges in process development of CAR T cell therapy

Induced Pluripotent Stem Cells in Regenerative Medicine

NK and Gamma Delta T based Allogenic Cell Therapy

Decoding the future of Healthcare; A comprehensive survey of cell therapy outcomes

Product development: commercialization and market

Regulatory Inspection – Challenges and Opportunities for Biosimilar Products

Regenerative medicine drug development in India: Challenges and Opportunities

Novel Biologics Development- A case study

Strategizing the challenges during clone development

Current challenges of development and cGMP manufacturing of Cell and Gene Therapy products

Induced Pluripotent Stem Cells (iPSC) In Disease Modelling and Drug Discovery

Panel Discussion: Biosimilars: Recent Advances in Cell Engineering and Upstream Processes for Accelerated, high quality and Affordable MAb development

Moderator

Panel Discussion: Cell and Gene Therapy- Progress, Challenges, and future outlook

Moderator

Bioassay: Advancement in functional assessment of biologics and regulatory requirements

Beyond the Blueprint: AI-Powered Protein Engineering for a Brighter Future

Scalable & Efficient Production of Lentiviral vectors

Collaboration of IP and Biosimilar R&D for Early Market Access

Bringing best practices to India in Design of Biopharmaceutical Facilities

Translating Cell and Gene Therapies- From Concept to Commercialization

 

Details on past conference